Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1978 2
1980 1
1984 1
1988 1
1989 1
1990 1
1996 1
1997 1
1998 1
2003 1
2004 1
2008 1
2009 2
2010 2
2011 2
2017 3
2018 2
2019 1
2020 3
2021 1
2022 3
2023 2
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

30 results

Results by year

Filters applied: . Clear all
Page 1
Postoperative risk of IDH-mutant glioma-associated seizures and their potential management with IDH-mutant inhibitors.
Drumm MR, Wang W, Sears TK, Bell-Burdett K, Javier R, Cotton KY, Webb B, Byrne K, Unruh D, Thirunavu V, Walshon J, Steffens A, McCortney K, Lukas RV, Phillips JJ, Mohamed E, Finan JD, Santana-Santos L, Heimberger AB, Franz CK, Kurz J, Templer JW, Swanson GT, Horbinski C. Drumm MR, et al. J Clin Invest. 2023 Jun 15;133(12):e168035. doi: 10.1172/JCI168035. J Clin Invest. 2023. PMID: 37104042 Free PMC article.
Experimentally, the metabolic product of IDHmut, d-2-hydroxyglutarate, rapidly synchronized neuronal spike firing in a seizure-like manner, but only when non-neoplastic glial cells were present. In vitro and in vivo models recapitulated IDHmut glioma-associated seiz …
Experimentally, the metabolic product of IDHmut, d-2-hydroxyglutarate, rapidly synchronized neuronal spike firing in a seizure-like manner, …
Surgical Management of Brain Tumors with Focused Ultrasound.
Mehkri Y, Pierre K, Woodford SJ, Davidson CG, Urhie O, Sriram S, Hernandez J, Hanna C, Lucke-Wold B. Mehkri Y, et al. Curr Oncol. 2023 May 13;30(5):4990-5002. doi: 10.3390/curroncol30050377. Curr Oncol. 2023. PMID: 37232835 Free PMC article. Review.
Currently, many clinical trials are currently underway for the treatment of non-neoplastic cranial pathologies and other non-cranial malignancies. ...
Currently, many clinical trials are currently underway for the treatment of non-neoplastic cranial pathologies and other non-c …
Nanotherapeutic treatment of the invasive glioblastoma tumor microenvironment.
Pandey N, Anastasiadis P, Carney CP, Kanvinde PP, Woodworth GF, Winkles JA, Kim AJ. Pandey N, et al. Adv Drug Deliv Rev. 2022 Sep;188:114415. doi: 10.1016/j.addr.2022.114415. Epub 2022 Jul 3. Adv Drug Deliv Rev. 2022. PMID: 35787387 Free PMC article. Review.
Developing therapies that can either directly target these brain-invading tumor cells or act on other cell types and molecular processes supporting tumor cell invasion and recurrence are essential steps in advancing new treatments in the clinic. This review highlights some …
Developing therapies that can either directly target these brain-invading tumor cells or act on other cell types and molecular proces …
Drug repurposing for the treatment of glioblastoma multiforme.
Abbruzzese C, Matteoni S, Signore M, Cardone L, Nath K, Glickson JD, Paggi MG. Abbruzzese C, et al. J Exp Clin Cancer Res. 2017 Nov 28;36(1):169. doi: 10.1186/s13046-017-0642-x. J Exp Clin Cancer Res. 2017. PMID: 29179732 Free PMC article. Review.
This is quite evident in glioblastoma, where a number of old drugs is now considered for clinical use, often in association with the first-line therapeutic intervention. Interestingly, most of these medications are, or have been, widely employed for decades in non- …
This is quite evident in glioblastoma, where a number of old drugs is now considered for clinical use, often in association with the first-l …
If it is Not a Glioblastoma, Then What is it? A Differential Diagnostic Review.
Gokden M. Gokden M. Adv Anat Pathol. 2017 Nov;24(6):379-391. doi: 10.1097/PAP.0000000000000170. Adv Anat Pathol. 2017. PMID: 28885262 Review.
In spite of its simple definition of presence of vascular proliferation and/or necrosis in a diffuse astrocytoma, the wide variety of cytohistomorphologic appearances overlap with many other neoplastic or non-neoplastic lesions. Here, after a brief review of gliobla …
In spite of its simple definition of presence of vascular proliferation and/or necrosis in a diffuse astrocytoma, the wide variety of cytohi …
Intramedullary lesions of the conus medullaris: differential diagnosis and surgical management.
Ebner FH, Roser F, Acioly MA, Schoeber W, Tatagiba M. Ebner FH, et al. Neurosurg Rev. 2009 Jul;32(3):287-300; discussion 300-1. doi: 10.1007/s10143-008-0173-1. Epub 2008 Sep 27. Neurosurg Rev. 2009. PMID: 18820958 Review.
Epidemiological, clinical and neuroradiological characteristics of neoplastic (glial tumors, non-glial tumors, metastasis, primary melanomas) and non-neoplastic lesions (granulomatous lesions, abscess, parasitic infections, vascular, demyelinating and dysembryogenet …
Epidemiological, clinical and neuroradiological characteristics of neoplastic (glial tumors, non-glial tumors, metastasis, primary melanomas …
Diagnosis and management of Rosai-Dorfman disease involving the central nervous system.
Adeleye AO, Amir G, Fraifeld S, Shoshan Y, Umansky F, Spektor S. Adeleye AO, et al. Neurol Res. 2010 Jul;32(6):572-8. doi: 10.1179/016164109X12608733393836. Epub 2010 Mar 26. Neurol Res. 2010. PMID: 20350368 Review.
INTRODUCTION: Rosai-Dorfman disease is a benign non-neoplastic proliferative disorder of histiocytes originally described in the cervical lymph nodes. ...RESULTS: By December 2008, 111 cases of Rosai-Dorfman disease involving the central nervous …
INTRODUCTION: Rosai-Dorfman disease is a benign non-neoplastic proliferative disorder of histiocytes originally describ …
Prenatal ultrasonographic diagnosis of fetal intracranial tumors: a review.
Sherer DM, Onyeije CI. Sherer DM, et al. Am J Perinatol. 1998 May;15(5):319-28. doi: 10.1055/s-2007-993951. Am J Perinatol. 1998. PMID: 9643639 Review.
Our objective was to review current literature pertaining to prenatal ultrasonography of various fetal intracranial neoplastic and non-neoplastic tumors. To this goal, all manuscripts published in the English language regarding this topic obtained from a MEDLINE sea …
Our objective was to review current literature pertaining to prenatal ultrasonography of various fetal intracranial neoplastic and non …
Accuracy of the 10 mug desmopressin test for differential diagnosis of Cushing syndrome: a systematic review and meta-analysis.
Giampietro RR, Cabral MVG, Pereira EG, Machado MC, Vilar L, Nunes-Nogueira VDS. Giampietro RR, et al. Front Endocrinol (Lausanne). 2024 Jan 30;15:1332120. doi: 10.3389/fendo.2024.1332120. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 38352712 Free PMC article.
We evaluated the accuracy of the 10 mug desmopressin test in differentiating Cushing disease (CD) from non-neoplastic hypercortisolism (NNH) and ectopic ACTH syndrome (EAS). A systematic review of studies on diagnostic test accuracy in patients with CD, NNH, or EAS …
We evaluated the accuracy of the 10 mug desmopressin test in differentiating Cushing disease (CD) from non-neoplastic hypercor …
NIH conference. Somatostatin and somatostatin analogue (SMS 201-995) in treatment of hormone-secreting tumors of the pituitary and gastrointestinal tract and non-neoplastic diseases of the gut.
Gorden P, Comi RJ, Maton PN, Go VL. Gorden P, et al. Ann Intern Med. 1989 Jan 1;110(1):35-50. doi: 10.7326/0003-4819-110-1-35. Ann Intern Med. 1989. PMID: 2535688 Review.
Eighty-five percent of patients with pancreatic islet cell tumors that produce vasoactive intestinal peptide will respond to SMS 201-995 with a reduction in diarrhea that often has been resistant to all other therapy. SMS 201-995 may also be useful in treating the symptoms …
Eighty-five percent of patients with pancreatic islet cell tumors that produce vasoactive intestinal peptide will respond to SMS 201-995 wit …
30 results